Lithium is the oldest and most extensively studied mood stabilizer in psychiatry. Used for over seventy years to treat bipolar disorder, lithium remains the gold standard for preventing both manic and depressive episodes. It is the only psychiatric medication with strong evidence for reducing suicide risk — a property that no other mood stabilizer or antidepressant has convincingly demonstrated.
Lithium is a naturally occurring element (the lightest metal on the periodic table) that was first used therapeutically in 1949. Today it is available as lithium carbonate (Lithobid, Eskalith) and lithium citrate (liquid formulation). Despite the availability of newer medications, lithium continues to be a first-line treatment for bipolar disorder in major clinical guidelines worldwide.
The exact mechanism by which lithium stabilizes mood is not fully understood, but research has identified several key actions. Lithium modulates intracellular signaling pathways (particularly the inositol phosphate and GSK-3 pathways), enhances serotonergic neurotransmission, increases neuroprotective factors like BDNF (brain-derived neurotrophic factor), and reduces excitatory glutamate signaling. This combination of effects provides both acute antimanic action and long-term neuroprotection.
Uniquely among psychiatric medications, lithium has demonstrated neuroprotective properties — it may actually increase gray matter volume in key brain regions affected by bipolar disorder. This neuroprotective effect, combined with its anti-suicidal properties, makes lithium a truly distinct medication in psychiatry.
Lithium is FDA-approved for the treatment of acute mania and maintenance therapy in bipolar disorder. It is effective across the full spectrum of bipolar illness — reducing the frequency, severity, and duration of both manic and depressive episodes. For acute mania, lithium can be combined with an antipsychotic like Seroquel or Abilify for more rapid stabilization.
For maintenance treatment, lithium is often the foundation upon which other medications are layered. Lamotrigine may be added for enhanced protection against depressive episodes, while antipsychotics may be used during breakthrough episodes. Lithium is also used off-label to augment antidepressants for treatment-resistant depression — a strategy with strong evidence dating back decades.
Common side effects include increased thirst and urination, fine hand tremor, weight gain, gastrointestinal discomfort (nausea, diarrhea), and cognitive dulling. Many of these effects are dose-related and can be managed by adjusting the dose or timing. Taking lithium with meals reduces GI symptoms, and extended-release formulations can minimize peak-related side effects like tremor.
Long-term lithium use requires monitoring for thyroid dysfunction (hypothyroidism occurs in approximately 20 to 30 percent of long-term users) and kidney function changes. Regular blood work — including lithium levels, thyroid function (TSH), and kidney function (creatinine, eGFR) — is mandatory. Thyroid changes are usually manageable with thyroid hormone replacement and do not require stopping lithium.
Lithium toxicity is the most serious acute risk. Because lithium has a narrow therapeutic window (blood levels of 0.6 to 1.2 mEq/L for maintenance), dehydration, sodium restriction, and certain medications (particularly NSAIDs and ACE inhibitors) can dangerously increase lithium levels. Symptoms of toxicity include severe tremor, confusion, vomiting, and unsteadiness — requiring immediate medical attention.
Lithium is one of the few psychiatric medications that requires regular blood level monitoring. After starting lithium, blood levels are typically checked five to seven days after each dose change (drawn twelve hours after the last dose). Once stable, monitoring shifts to every three to six months. Thyroid and kidney function are checked at baseline, every six months for the first year, and annually thereafter.
Staying well-hydrated and maintaining consistent sodium intake are essential while taking lithium. Adults should drink adequate water daily and avoid sudden changes in diet, intense exercise without hydration, or prolonged heat exposure — all of which can concentrate lithium in the blood.
Lithium management requires experienced psychiatric care and consistent monitoring. At Elevate Psychiatry, our board-certified psychiatrists provide comprehensive bipolar evaluations, lithium initiation and monitoring, and individualized medication management for adults in Miami and throughout Florida via telehealth.
Schedule an appointment to discuss lithium and other bipolar treatment options.
This content is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified psychiatrist before starting, changing, or stopping any medication.
